logo
logo

Invitae Announces $1.15 Billion Investment Supporting Ongoing Growth Initiatives

Apr 05, 2021•over 4 years ago

Amount Raised

$1.15 Billion

San Francisco

Description

Invitae (NYSE: NVTA), a leading medical genetics company, today announced that a small group of investors, led by SB Management, a subsidiary of Softbank Group Corp., will make an investment of $1.15 billion in convertible senior notes to support the Company's future growth initiatives.

Company Information

Company

Invitae

Location

San Francisco, California, United States

About

Invitae Corporation (NYSE: NVTA) is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. For more information, visit the company's website at invitae.com.